Related Experiment Video
Updated: Jan 29, 2026

Parasite Induced Genetically Driven Autoimmune Chagas Heart Disease in the Chicken Model
Published on: July 29, 2012
Chagas Cardiomyopathy in Latin America Review
Jefferson Luis Vieira1, Fábio Rocha Fernandes Távora2, Maria Gyslane Vasconcelos Sobral2
1Messejana Heart and Lung Hospital Dr. Carlos Alberto Studart Gomes, Av. Frei Cirilo, 3480 Messejana, Fortaleza, CE, 60.846-190, Brazil. jefvieira@yahoo.com.br.
Insights
Chagas cardiomyopathy, a growing global concern, presents unique challenges in heart failure management. Mechanical circulatory support shows promise for bridging Chagas patients to heart transplantation, offering better outcomes than in non-Chagas patients.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Chagas cardiomyopathy is a significant public health issue in Latin America, increasingly prevalent worldwide due to migration.
- It leads to heart failure and poses a substantial health and economic burden.
- Understanding its clinical, epidemiological, and treatment aspects is crucial.
Purpose of the Study:
- To review the clinical and epidemiological features of Chagas cardiomyopathy.
- To discuss specific treatment principles, including antiparasitic therapy and heart transplantation.
- To assess the institutional experience with mechanical circulatory support in refractory heart failure due to Chagas cardiomyopathy.
Main Methods:
- Retrospective analysis of institutional data over a 10-year period.
- Focus on patients with refractory heart failure caused by Chagas cardiomyopathy.
- Evaluation of outcomes related to mechanical circulatory support and heart transplantation.
Main Results:
- Antiparasitic treatment for heart failure in Chagas cardiomyopathy remains controversial.
- Heart transplantation is an established option for Chagas cardiomyopathy.
- Mechanical circulatory support in Chagas patients demonstrated more successful bridging to heart transplantation compared to non-Chagas patients.
Conclusions:
- Chagas patients may have favorable characteristics for mechanical circulatory support in advanced heart failure.
- Mechanical circulatory support is a viable and effective option for bridging Chagas cardiomyopathy patients to heart transplantation.
- Further research is needed, but current institutional experience supports its use.
Purpose Of Review:
Chagas cardiomyopathy is a major public health disease in Latin America and, due to migration, is becoming a worldwide health and economic burden. This review sought to present the clinical and epidemiological aspects of Chagas cardiomyopathy, as well as some specific features and principles of treatment. We also retrospectively assessed our institutional experience with mechanical circulatory support in refractory heart failure due to Chagas cardiomyopathy over a 10-year period.
Recent Findings:
The role of antiparasitic treatment in patients with heart failure due to Chagas cardiomyopathy is controversial. Heart transplantation, although formerly contraindicated, is currently established as an important therapeutic option. Also, the favorable characteristics of Chagas patients, such as younger age, little comorbidity, and no reoperations or severe pulmonary hypertension, could be an advantage for a mechanical circulatory support indication in advanced heart failure due to Chagas cardiomyopathy. Despite the absence of large evidence-based data, much has been accomplished since Carlos Chagas' discovery one century ago. Our institutional experience shows that mechanical circulatory support in Chagas patients is associated with more successful bridging to heart transplantation when compared to non-Chagas patients.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Cardiomyopathy V: Interprofessional Care

